ARVEE
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
This data is currently unavailable for this company.
Events:
Bonus
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Arvee Laboratories do?
Arvee Laboratories in India focuses on producing innovative and eco-friendly Polymer Modifiers, Contrast Media Intermediates, and Drug Intermediates for both domestic and global markets, aiming to lead the chemical industry with competitive pricing.
Who are the competitors of Arvee Laboratories?
Arvee Laboratories major competitors are ARCL Organics, Renol Polychem, Patel Chem Specialit, Sadhana Nitro Chem, Dai-Ichi Karkaria, Indian Emulsifiers, Chembond Mat.Techno. Market Cap of Arvee Laboratories is ₹185 Crs. While the median market cap of its peers are ₹185 Crs.
Is Arvee Laboratories financially stable compared to its competitors?
Arvee Laboratories seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Arvee Laboratories pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Arvee Laboratories latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Arvee Laboratories allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments, Accounts Receivable
How strong is Arvee Laboratories balance sheet?
Balance sheet of Arvee Laboratories is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Arvee Laboratories improving?
The profit is oscillating. The profit of Arvee Laboratories is ₹2.07 Crs for TTM, ₹2.15 Crs for Mar 2025 and ₹1.05 Crs for Mar 2024.
Is the debt of Arvee Laboratories increasing or decreasing?
Yes, The net debt of Arvee Laboratories is increasing. Latest net debt of Arvee Laboratories is -₹5.86 Crs as of Sep-25. This is greater than Mar-25 when it was -₹8.64 Crs.
Is Arvee Laboratories stock expensive?
Arvee Laboratories is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE. Latest PE of Arvee Laboratories is 89.24, while 3 year average PE is 99.11. Also latest EV/EBITDA of Arvee Laboratories is 77.35 while 3yr average is 40.83.
Has the share price of Arvee Laboratories grown faster than its competition?
Arvee Laboratories has given better returns compared to its competitors. Arvee Laboratories has grown at ~26.09% over the last 1yrs while peers have grown at a median rate of -36.58%
Is the promoter bullish about Arvee Laboratories?
Promoters seem to be bullish about the company. Latest quarter promoter holding is 73.51% and last quarter promoter holding is 73.5%.
Are mutual funds buying/selling Arvee Laboratories?
There is Insufficient data to gauge this.
